EMFO LLC’s Traws Pharma TRAW Stock Holding History

EMFO LLC’s Portfolio TRAW Stock Details TRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-133	Closed	-$3K	–	325
2022 Q3	$3K	Hold	133	–	–	﹤0.01%	304
2022 Q2	$4K	Hold	133	–	–	﹤0.01%	306
2022 Q1	$6K	Hold	133	–	–	0.01%	304
2021 Q4	$8K	Hold	133	–	–	0.01%	302
2021 Q3	$13K	Hold	133	–	–	0.01%	292
2021 Q2	$23K	Buy	+133	New	+$30.1K	0.02%	238

Other funds holding TRAW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

BPA

Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return

TSS

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

EMFO LLC's TRAW Position: Q4 2022 in Review

EMFO LLC sold out of Traws Pharma (TRAW) in Q4 2022, closing a stake of 133 shares — an estimated $3K sold.

EMFO LLC first reported a position in TRAW in Q2 2021 and held it in 6 quarters. The position peaked at $23K in Q2 2021. 28 funds tracked by Wall St. Rank hold TRAW as of Q4 2022.

EMFO LLC reported no remaining Traws Pharma position as of Q4 2022 after selling out during the quarter.
EMFO LLC sold 133 Traws Pharma shares in Q4 2022, an estimated $3K.
EMFO LLC first reported a position in Traws Pharma in Q2 2021 and held it in 6 quarters.
EMFO LLC's Traws Pharma position peaked at $23K in Q2 2021.
28 funds tracked by Wall St. Rank held Traws Pharma as of Q4 2022.

Based on EMFO LLC's 13F filing for Q4 2022, filed 2 Feb 2023.